Zobrazeno 1 - 10
of 203
pro vyhledávání: '"U, Vanhoefer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
H. Vogelsang, Stefan Mönig, C. Kuhn, Lars Grenacher, Wolfgang Fischbach, Andrea Tannapfel, Markus Moehler, Wh-H. Schmiegel, J. Bernhardt, Michael Stahl, T. Rabenstein, C. Stoll, Hubert J. Stein, Stephan Kanzler, A. Weimann, Manfred P. Lutz, J. Körber, Michael Flentje, P. Rohr, R. Porschen, U. Vanhoefer, Markus Horneber, I. Roetzer, Hj-J. Meyer, J. Fahlke, Bj J. Krause, T. Andus, Pm M. Schlag, Frank Kullmann, P. Baier, K. Ridwelski, W. Schepp, B. Herbst, Helmut Messmann, U. Wedding, Wa A. Diemer, Pr R. Galle, E. Burmester, Ah H. Hölscher, He E. Gabbert, C. Ell, Florian Lordick, S. Groß, H. Boeing, G. Klautke, J. Seraphin, E. Böhle, Cf F. Dietrich, Rd D. Hofheinz, MP Ebert, Dirk Arnold, A. Eickhoff, Christian Jenssen, W. Budach, K. Ludwig, T. Seufferlein, K. Treml, A. Sendler, M. Heike, H. Wilke, R. Tholen, Rainer Fietkau, T. Höhler, H. Feußner, M Vieth, W. Fleig, Michael Selgrad, S. Merkel, Ch. Wittekind, Peter C. Thuss-Patience, Heinz Höfler, Gustavo B. Baretton, Peter Malfertheiner, M. Keller, Carsten Bokemeyer, Ralf Kiesslich, Ines Gockel, Jan Bornschein, Christoph Röcken, Steffen Pistorius, M. Geissler, Kerstin Schütte, G. Schuch, D. Wagner, Christoph Schuhmacher, R. Jakobs, U. Graeven, H. Lang, P. Piso, W. Schwenk, Hj-J. Schmoll, M. Anthuber, Jt T. Hartmann, J. Hübner, S. Höcht, J. R. Izbicki, Volker Heinemann, Daniela Aust, R. Mahlberg, Hartmut Link, Heinz Schmidberger, RM Schmid, P. Reichardt, Se-E. Al-Batran, Martin Stuschke, Thomas Herrmann, K. Caca, Jann Arends
Publikováno v:
Zeitschrift für Gastroenterologie. 49:461-531
Autor:
U. Vanhoefer
Publikováno v:
best practice onkologie. 2:24-32
Autor:
Jinping Wang, Bertram Wiedenmann, U. Vanhoefer, William P. Steward, Dirk Laurent, Tanja Trarbach, Andrew Henry, Martina Poethig, Eric Masson, Cordula Bartel, Anne L. Thomas
Publikováno v:
Annals of Oncology. 18:782-788
Background: This open-label, phase IB study was undertaken to determine the safety/toxicity profile and recommended dose of oral once-daily PTK787/ZK 222584 (PTK/ZK) combined with oxaliplatin/5-fluorouracil (5-FU)/leucovorin (FOLFOX4) chemotherapy in
Publikováno v:
Laboratory Animals. 41:239-246
The implantation of tumour cells in normal tissues and the subsequent induction of angiogenesis by the growing xenograft were studied by means of immunohistochemistry and digital image analysis. Tumour growth was induced by injection of a human spind
Autor:
R, Porschen, A, Buck, W, Fischbach, I, Gockel, U, Görling, L, Grenacher, S, Hollerbach, A, Hölscher, J, Körber, H, Messmann, H J, Meyer, S, Miehlke, M, Möhler, U, Nöthlings, U, Pech, H, Schmidberger, M, Schmidt, M, Stahl, M, Stuschke, P, Thuss-Patience, J, Trojan, U, Vanhoefer, A, Weimann, F, Wenz, C, Wullstein
Publikováno v:
Zeitschrift fur Gastroenterologie. 53(11)
Publikováno v:
Cancer Chemotherapy and Pharmacology. 59:703-709
Intravenous (i.v.) vinorelbine (VRL) generally given on days 1 and 8 of an every three-week cycle in combination with paclitaxel (PTX) is an effective option for the treatment of metastatic breast cancer (MBC). In an effort to improve both patient an
Autor:
U. Vanhoefer
Publikováno v:
Seminars in Oncology. 32:7-10
Targeted therapies that are approved for metastatic colorectal cancer are divided into two groups: those affecting vascular endothelial growth factor (VEGF) known to interrupt tumor growth and metastasis (also called neo-angiogenesis), and agents tha
Autor:
M.P. Lutz, E. van Cutsem, T. Langenbuch, H.-G. Mergenthaler, B. Genicot, U. Vanhoefer, R. Fuchs, Ö. Anak, P. Reichardt, P. Rougier, C.-H. Köhne, M. El-Serafi, B. Nordlinger, M. Lorenz, Jacques Wils, N. Frickhofen, C. Bokemeyer, H. Rückle-Lanz, L. Müller, R. Voigtmann
Publikováno v:
Journal of Clinical Oncology. 23:4856-4865
Purpose To demonstrate that adding irinotecan to a standard weekly schedule of high-dose, infusional fluorouracil (FU) and leucovorin (folinic acid [FA]) can prolong progression-free survival (PFS). Patients and Methods Four hundred thirty patients w